dimethylcarbamothioic morpholine-4-carbothioicthioanhydride | 30887-90-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: dimethylcarbamothioic morpholine-4-carbothioicthioanhydride
• 英文别名: Dimethylthiocarbamyl-morpholinothiocarbonyl-sulfid；morpholinodimethylamino(thiocarbonyl)monosulfide；dimethyl-thiocarbamic morpholine-4-carbothioic thioanhydride；Dimethylcarbamothioyl morpholine-4-carbodithioate
• CAS: 30887-90-2
• 化学式: C₈H₁₄N₂OS₃
• 分子量: 250.41
• InChiKey: CWOLIIXBWRRZPE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  105
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  triethylammonium morpholinodithiocarbamate 、 二甲氨基硫代甲酰氯 以 乙腈 为溶剂， 生成 dimethylcarbamothioic morpholine-4-carbothioicthioanhydride
  参考文献：
  名称：

  Bis(dialkylaminethiocarbonyl)disulfides as Potent and Selective Monoglyceride Lipase Inhibitors

  摘要：

  Monoglyceride lipase (MGL) inhibition may offer an approach in treating diseases in which higher 2-arachidonoyglycerol activity would be beneficial. We report here the synthesis and pharmacological evaluation of bis(dialkylaminethiocarbonyl)disulfide derivatives as irreversible MGL inhibitors. Inhibition occurs through interactions with MGL C208 and C242 residues, and these derivatives exhibit high inhibition selectivity over fatty acid amide hydrolase, another endocannabinoid-hydrolyzing enzyme.

  DOI：

  10.1021/jm901323s

文献信息

• [EN] SERINE BIOSYNTHETIC PATHWAY INHIBITORS<br/>[FR] INHIBITEURS DE LA VOIE DE BIOSYNTHÈSE DE LA SÉRINE
  申请人：UNIV CATHOLIQUE LOUVAIN

  公开号：WO2017157882A1

  公开（公告）日：2017-09-21

  The present invention relates to a compound of formula (I), a stereoisomer thereof, an enantiomer thereof, a racemic thereof, or a tautomer thereof as defined in claim 1 (I) the present invention also relates to a compound of formula (I), a stereoisomer thereof, an 5 enantiomer thereof, a racemic thereof, or a tautomer thereof, as defined in the claims for use as a medicament, in particular for use in the prevention or treatment of a cellular proliferative disease.

  本发明涉及公式(I)的化合物，其立体异构体，对映异构体，消旋体或互变异构体，如权利要求1中定义的(I)。本发明还涉及公式(I)的化合物，其立体异构体，对映异构体，消旋体或互变异构体，如权利要求中定义的用作药物，特别是用于预防或治疗细胞增殖性疾病。
• Substituted carbamothioic amine-1-carbothioic thioanhydrides as novel trichomonicidal fungicides: Design, synthesis, and biology
  作者：Dhanaraju Mandalapu、Bhavana Kushwaha、Sonal Gupta、Shagun Krishna、Nidhi Srivastava、Mahendra Shukla、Pratiksha Singh、Bhavana S. Chauhan、Ravi Goyani、Jagdamba P. Maikhuri、Koneni V. Sashidhara、Brijesh Kumar、Renu Tripathi、Praveen K. Shukla、Mohammad I. Siddiqi、Jawahar Lal、Gopal Gupta、Vishnu L. Sharma

  DOI：10.1016/j.ejmech.2017.11.060

  日期：2018.1

  Sexually transmitted diseases like trichomoniasis along with opportunistic fungal infections like candidiasis are major global health burden in female reproductive health. In this context a novel non-nitroimidazole class of substituted carbamothioic amine-1-carbothioic thioanhydride series was designed, synthesized, evaluated for trichomonacidal and fungicidal activities, and was found to be more active than the standard drug Metronidazole (MTZ). Compounds were trichomonicidal in the MIC ranges of 4.77-294.1 mu M and 32.46-735.20 mu M against MTZ-susceptible and-resistant strains, respectively. Further, compounds inhibited the growth of at least two out of ten fungal strains tested at MIC of 7.50 -240.38 mu M. The most active compound (20) of this series was 3.8 and 9.5 fold more active than the MTZ against the two Trichomonas strains tested. Compound 20 also significantly inhibited the sulfhydryl groups present over Trichomonas vaginalis and was found to be more active than the MTZ in vivo. Further, a docking analysis carried out with cysteine proteases supported their thiol inhibiting ability and preliminary pharmacokinetic study has shown good distribution and systemic clearance. (C) 2017 Elsevier Masson SAS. All rights reserved.
• DAMISO J. J.; MORITA E., PHOSPH. AND SULFUR, 1977, 3, NO 2, 255-256
  作者：DAMISO J. J.、 MORITA E.

  DOI：——

  日期：——
• Bis(dialkylaminethiocarbonyl)disulfides as Potent and Selective Monoglyceride Lipase Inhibitors
  作者：Coco N. Kapanda、Giulio G. Muccioli、Geoffray Labar、Jacques H. Poupaert、Didier M. Lambert

  DOI：10.1021/jm901323s

  日期：2009.11.26

  Monoglyceride lipase (MGL) inhibition may offer an approach in treating diseases in which higher 2-arachidonoyglycerol activity would be beneficial. We report here the synthesis and pharmacological evaluation of bis(dialkylaminethiocarbonyl)disulfide derivatives as irreversible MGL inhibitors. Inhibition occurs through interactions with MGL C208 and C242 residues, and these derivatives exhibit high inhibition selectivity over fatty acid amide hydrolase, another endocannabinoid-hydrolyzing enzyme.